Table 1: Clinical and Direct Immunofluorescent S of All patients from group B (immune complex mediated glomerulopathy)

 

Diagnosis

Original Staining

for IgG/κ/λ

1st F-U

(months)

1st F-U staining

for IgG/κ/λ

2nd F-U

(months)

2nd F-U staining

for IgG/κ/λ

MGN

2+/2+/2+

17.5

3+/2+/2+

57.5

1+/1+/1+

MGN

3+/3+/2+

17.5

3+/3+/1+

57.5

1+/1+/0

LN Class 3+5

3+/2+/2+

16.5

3+/3+/2+

56.5

1+/0/0

MGN

3+/2+/2+

16

3+/2+/2+

56

N/A

LN Class 3+5

2+/1+/1+

15

3+/2+/2+

55

1+/0/1+

MPGN Type 3

3+/3+/3+

15

3+/3+/2+

55

1+/1+/1+

MGN

3+/2+/2+

14.5

3+/2+/2+

54.5

1+/1+/1+

LN Class 4

3+/3+/3+

14.5

2+/2+/2+

54.5

1+/1+/1+

LN Class 2

3+/2+/1+

14

1+/1+/1+

54

1+/1+/0

LN Class 3+5

3+/1+/1+

12.5

2+/2+/2+

52.5

2+/1+/1+

MGN

3+/3+/3+

12.5

3+/2+/1+

52.5

1+/0/0

MPGN

3+/2+/1+

12.5

2+/1+/1+

52.5

1+/0/1+

LN Class 5

3+/3+/2+

12

2+/1+/1+

52

1+/0/1+

MGN

3+/3+/3+

11.5

3+/2+/2+

51.5

1+/1+/0

LN Class 4+5

3+/2+/1+

10.5

3+/2+/3+

50.5

1+/0/1+

MGN

3+/3+/2+

10.5

3+/3+/2+

50.5

1+/1+/1+

LN Class 4+5

3+/3+/2+

9.5

2+/2+/2+

49.5

1+/0/0

MGN

3+/2+/2+

8.5

3+/3+/2+

48.5

2+/1+/1+

MGN

3+/2+/2+

8.5

3+/2+/2+

48.5

1+/1+/1+

LN Class 5

3+/3+/3+

7.5

2+/2+/2+

47.5

N/A

MGN

3+/1+/1+

7.5

2+/1+/1+

47.5

1+/1+/0

MGN

3+/3+/3+

7.5

3+/2+/2+

47.5

1+/1+/0

LN Class 5

3+/3+/3+

5.5

3+/3+/3+

45.5

2+/1+/2+

LN Class 4

3+/2+/2+

5.5

2+/2+/2+

45.5

2+/2+/1+

MGN

3+/2+/2+

5

3+/2+/2+

45

2+/0/1+

LN Class 4

2+/3+/2+

5

2+/3+/2+

45

0/1+/1+

MGN

3+/3+/3+

4.5

3+/3+/3+

44.5

2+/1+/1+

LN Class 4+5

2+/3+/3+

3.5

3+/3+/3+

43.5

N/A

MPGN

2+/2+/2+

3.5

2+/2+/2+

43.5

0/0/1+

LN Class 4

3+/2+/3+

2

2+/2+/3+

42

1+/1+/1+

LN Class 4+5

3+/2+/3+

1

3+/3+/3+

41

2+/2+/2+

LN Class 5

3+/1+/2+

1

3+/1+/2+

41

2+/0/0

MGN

3+/3+/3+

1

3+/3+/2+

41

2+/2+/2+

 LN Class 5+3

3+/3+/3+

1

3+/3+/3+

41

2+/2+/2+

Acute Post-Infectious GN

3+/2+/2+

1

3+/2+/2+

41

1+/1+/2+